Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Sale/leaseback of chemical company facilities in North Carolina
Represented chemical company in the sale/leaseback of significant office and laboratory facilities in North Carolina. more
In re: Teflon products liability litigation

Jointly represented DuPont in the “Teflon” multi-district consumer fraud litigation. The multi-district litigation consolidated over 24 more

Trademark services for American Eagle Outfitters, Inc.
Represents American Eagle Outfitters, Inc., the leading youth lifestyle brand, in intellectual property matters. more
Counsel for infrastructure company
Represented infrastructure company in connection with several toll road projects. more